Screening | Randomization | Treatment | Follow up | |||||
---|---|---|---|---|---|---|---|---|
M3 | M6 | Y1 | Y2 | Y3 | ||||
History & physical | X | X | X | X | X | X | X | |
Brain CT or MRI | X | X | X | X | X | |||
TAP CT | X | X | X | X | X | |||
FDG PET or F-Choline PET | X | X | ||||||
PET or SPECT-CT | X | X | ||||||
Spinal MRI (if spinal bone metastases) | X | X | X | |||||
Mammography (breast cancer) | X | X | X | X | X | |||
Histological confirmation | X | |||||||
Quality of Life | X | X | X | X | X | X | X | |
Toxicity Assessment | X | X | X | X | X | X | ||
Pain Assessment | X | X | X | X | X | X | X | |
Economic Study | X | X | X | X | X | X | ||
sCTX/ bALP Evaluation | X | X | X | X | X |